The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Single-port laparoscopic nephrectomy.
If a kidney is affected by cancer or irreversibly damaged, it may need to be removed. Removal of a kidney (nephrectomy) can be done as an open operation or through ‘keyhole surgery’ using several small incisions (laparoscopy). This procedure aims to produce less scarring and discomfort than traditional open or laparoscopic nephrectomy, by using a single ‘keyhole’.
M02.- Total excision of kidney
Y75.2 Laparoscopic approach to abdominal cavity NEC
Note: A fourth character must be selected from category M02.- Total excision of kidney to further specify the type of nephrectomy performed.
It is not possible to capture the fact that the procedure was performed through a single umbilical port.
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new interventional procedures. The guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Providers should ensure that governance structures are in place to review, authorise and monitor the introduction of new devices and procedures.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.